Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01119326 · ClinicalTrials.gov registry record · Phase 1
Autologous Fat Transfer for Scar Prevention and Remodeling
A Phase 1 study of Wound, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 3
- Study locations
NCT01119326: Completed Phase 1 study of Wound, sponsored by University of Florida.
NCT01119326 is a Phase 1 study of Wound that has completed, run by University of Florida. The registered enrollment target is 14 participants, below the 424-participant average among 8 other Wound trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01119326, a Phase 1 study of Wound, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to find out if it is safe and feasible to improve the appearance and quality of a scar by using a procedure in which adipose tissue (fat) is taken from other parts of your body and injected, or transplanted into a scar. This procedure is called autologous fat transfer (AFT). The main goal of this study is to see if AFT is safe and can improve the quality and appearance of scar tissue. Another main goal is to determine how much tissue should be transplanted to get the best results.
Primary Outcome
If no Dose Limiting Toxicity (DLT) is observed ,dose escalation will occur. Study sites/scars will be delineated by tracings, digital photography,scar assessment scale,and measures of scar elasticity and color. To correlate efficacy with graft quality, a sample of each adipose harvest will be sent to the laboratory for quantitative analysis of the stromal vascular fraction (SVF) with the adipose sample.
Conditions Studied
Interventions
- PROCEDURE Autologous Fat Transfer
Study Locations (3)
Florida
- University of Florida - Gainesville
Texas
- Institute of Surgical Research (ISR)/Brooke Army Medical Center (BAMC) - Fort Sam Houston
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2010-04 |
| Est. Completion | 2017-06 |
| Phase | Phase 1 |
What the finished NCT01119326 record still lists
NCT01119326 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 424-participant average among 8 other Wound trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Wound appearing as the primary indexed condition, and to 1 intervention - of which Autologous Fat Transfer is the first listed.
NCT01119326 reports a single indexed study location in Florida, Texas, Virginia.
Frequently Asked Questions
What is clinical trial NCT01119326 about?
NCT01119326 is a clinical study titled "Autologous Fat Transfer for Scar Prevention and Remodeling". The purpose of this research study is to find out if it is safe and feasible to improve the appearance and quality of a scar by using a procedure in which adipose tissue (fat) is taken from other parts of your body and injected, or transplanted into a scar. This procedure is called autologous fat tr...
What is the current status of trial NCT01119326?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2010-04. Estimated completion is 2017-06.
What conditions does trial NCT01119326 study?
This clinical trial studies the following conditions: Wound.
What interventions are being tested in trial NCT01119326?
The interventions under investigation include: Autologous Fat Transfer (PROCEDURE).
Who is sponsoring clinical trial NCT01119326?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01119326 being conducted?
This trial has 3 study locations across Florida, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01119326's enrollment target sits among peer trials
14 9th of 8 the lowest of 8 other Wound trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Novel Strategies for Reducing Burn Scar Itch
RECRUITING · Phase 3
-
Miro3D Randomized Controlled Trial (RCT)
RECRUITING · NA
-
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
RECRUITING · Phase 3
-
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dressing
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia